Department of Medical and Surgical Sciences, University of Foggia, C.U.R.E. Centre for Liver Disease Research and Treatment, Ospedali Riuniti, Viale Luigi Pinto 1, 71122 Foggia, Italia.
Curr Pharm Des. 2014;20(18):2978-92. doi: 10.2174/13816128113196660700.
The present review points out the role of oxidative stress in aging and the potential therapeutic targets of modern antioxidant therapies. Mitochondria are essential for several biological processes including energy production by generating ATP through the electron transport chain (ETC) located on the inner mitochondrial membrane. Due to their relevance in cellular physiology, defects in mitochondria are associated with various human diseases. Moreover, several years of research have demonstrated that mitochondria have a pivotal role in aging. The oxidative stress theory of aging suggests that mitochondria play a key role in aging as they are the main cellular source of reactive oxygen species (ROS), which indiscriminately damage macromolecules leading to an age-dependent decline in biological function. In this review we will discuss the mitochondrial dysfunction occurring in aging. In particular, we will focus on the novel mitochondria targeted therapies and the new selective molecules and nanocarriers technology as potentially effective in targeting mitochondrial dysfunction and diseases involving oxidative stress and metabolic failure.
本文指出了氧化应激在衰老过程中的作用,以及现代抗氧化治疗的潜在治疗靶点。线粒体对于包括通过位于线粒体内膜上的电子传递链(ETC)生成 ATP 来进行能量产生在内的多种生物过程至关重要。由于其在细胞生理学中的重要性,线粒体缺陷与各种人类疾病有关。此外,多年的研究已经证明线粒体在衰老过程中起着关键作用。衰老的氧化应激理论表明,线粒体在衰老中起着关键作用,因为它们是活性氧(ROS)的主要细胞来源,ROS 无差别地破坏大分子,导致生物功能随年龄的增长而下降。在这篇综述中,我们将讨论衰老过程中发生的线粒体功能障碍。特别是,我们将重点讨论新型靶向线粒体的治疗方法以及新的选择性分子和纳米载体技术,因为它们可能有效地针对涉及氧化应激和代谢衰竭的线粒体功能障碍和疾病。